Related Experiment Video

Updated: May 24, 2026

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
09:53

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

Published on: July 27, 2010

Mucocutaneous leishmaniasis in a patient treated with anti-TNF-α therapy

Estrella Garcia-Gonzalez, Giacomo M Guidelli, Marco Bardelli

    Rheumatology (Oxford, England)
    |March 20, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
    06:57

    In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

    Published on: February 20, 2020

    Related Experiment Videos

    Last Updated: May 24, 2026

    In vivo Imaging of Transgenic Leishmania Parasites in a Live Host
    09:53

    In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

    Published on: July 27, 2010

    In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice
    06:57

    In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

    Published on: February 20, 2020

    Related Concept Videos

    Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

    Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

    Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
    T Cell Types and Functions01:24

    T Cell Types and Functions

    When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
    Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

    Articles linked to this work by shared authors, journal, and citation graph.

    Plasma and urinary NMR metabolic profiling of the phenylalanine-tyrosine pathway in nitisinone-treated alkaptonuria: comparison of two dosing regimens and identification of a candidate pharmacodynamic biomarker.

    Molecular genetics and metabolism·2026

    Effectiveness and Safety of Recombinant Zoster Vaccine in Rheumatic Diseases: Real-World Evidence from a Single-Centre Italian Cohort.

    Vaccines·2025

    Extraordinary Response to Mitotane Monotherapy in Advanced Aggressive Adrenocortical Carcinoma.

    JCEM case reports·2025

    Enhancing Communication in Minimally Verbal Autistic Children: A Study on NAO-Assisted Therapy.

    Journal of clinical medicine·2025

    The Combination of Afternoon and Midnight Salivary Cortisol Improves the Diagnosis of Cushing Syndrome.

    The American journal of medicine·2025

    Obesity and fibromyalgia are associated with Difficult-to-Treat Rheumatoid Arthritis (D2T-RA) independent of age and gender.

    Arthritis research & therapy·2025

    Drug survival of adalimumab across different manifestations of Behçet's syndrome: a retrospective analysis in 335 patients.

    Rheumatology (Oxford, England)·2026

    Prevalence of dysautonomia in chronic musculoskeletal pain: a cross-sectional study.

    Rheumatology (Oxford, England)·2026

    A specific molecular profiling of secreted rheumatoid factors in Sjögren' s disease patients with lymphoma.

    Rheumatology (Oxford, England)·2026

    Comorbidity and mortality in adults with juvenile idiopathic arthritis: a nationwide Norwegian register-based matched cohort study.

    Rheumatology (Oxford, England)·2026

    Remission, low disease activity, and relapse in patients with juvenile-, adult-, and late-onset systemic lupus erythematosus.

    Rheumatology (Oxford, England)·2026

    Digital home monitoring in patients with juvenile idiopathic arthritis to increase intervals of hospital visits.

    Rheumatology (Oxford, England)·2026

    [Regulatory T Cells and Cancer-Focus on Renal Cell Carcinoma].

    Gan to kagaku ryoho. Cancer & chemotherapy·2026

    Identification of broadly tumour-reactive γδ TCRs from multiple myeloma.

    Nature·2026

    Immunogenic cell death and tertiary lymphoid structures: bridging tumour cell death and immune organization.

    Nature reviews. Immunology·2026

    Sentinel lymph node biopsy in melanoma: Redundant in the neoadjuvant era.

    European journal of cancer (Oxford, England : 1990)·2026

    Accountability and the seemingly imponderables in NHS patient safety.

    British journal of nursing (Mark Allen Publishing)·2026

    MG53 suppresses IRF7 to reprogram macrophages and promote antitumor immunity in pancreatic ductal adenocarcinoma.

    Cell reports·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us